Rockefeller Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-635
| Closed | -$1K | – | 3582 |
|
|
2022
Q4 | $1K | Hold |
635
| – | – | ﹤0.01% | 3753 |
|
|
2022
Q3 | $3K | Sell |
635
-288
| -31% | -$1.36K | ﹤0.01% | 3510 |
|
|
2022
Q2 | $3K | Sell |
923
-1,112
| -55% | -$3.61K | ﹤0.01% | 3690 |
|
|
2022
Q1 | $11K | Hold |
2,035
| – | – | ﹤0.01% | 3008 |
|
|
2021
Q4 | $15K | Buy |
2,035
+44
| +2% | +$324 | ﹤0.01% | 2789 |
|
|
2021
Q3 | $17K | Buy |
1,991
+1,491
| +298% | +$12.7K | ﹤0.01% | 2660 |
|
|
2021
Q2 | $5K | Sell |
500
-2,500
| -83% | -$25K | ﹤0.01% | 3042 |
|
|
2021
Q1 | $37K | Buy |
3,000
+2,900
| +2,900% | +$35.8K | ﹤0.01% | 2018 |
|
|
2020
Q4 | $1K | Sell |
100
-910
| -90% | -$9.1K | ﹤0.01% | 2775 |
|
|
2020
Q3 | $9K | Hold |
1,010
| – | – | ﹤0.01% | 2045 |
|
|
2020
Q2 | $9K | Buy |
1,010
+910
| +910% | +$8.11K | ﹤0.01% | 1933 |
|
|
2020
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 2306 |
|
|
2019
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 2003 |
|
|
2019
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1874 |
|